Bill Hawkins is retired Chairman and CEO of Medtronic and currently Lead Director of Immucor, Inc., a private company, wholly owned by TPG, a large Private Equity firm. Immucor is a leading provider of transfusion and transplantation diagnostic products worldwide. He is also active on public and private boards as well as non for profit boards.
Mr. Hawkins was President and CEO of Immucor from Oct 2011 to July 2015. Prior to Immucor Mr. Hawkins served as Chairman and CEO of Medtronic, one of the worlds’ largest and most innovative medical technology companies. Mr. Hawkins assumed the role of CEO in 2007 and became Chairman of the Board in 2008. He joined Medtronic in 2002 as SVP and President of Medtronic Vascular. He served in that role until June 2004 . From 2004 until August 2007 he was President and Chief Operating Officer of Medtronic.
Prior to Medtronic, Mr. Hawkins served as President and Chief Executive Officer of Novoste Corp. Nasdaq (NOVT) and held senior leadership positions at American Home Products, Johnson & Johnson, Guidant Corp., and Eli Lilly & Co. He began his medical technology career with Carolina Medical Electronics in 1977.
Mr. Hawkins received his bachelor’s degree in electrical and biomedical engineering from Duke in 1976, where he also conducted medical research in pathology. He then went on to earn an M.B.A. from the Darden School of Business, University of Virginia, in 1982.
He serves as a Director of Halyard Health NYSE:HYH and Chairman of the Board of KeraNetics . Mr. Hawkins is the Chairman and co Founder of the Medical Device Innovation Consortium (“MDIC”), and past-president of the American Institute of Medical and Biological Engineering (“AMIBE”). Mr. Hawkins was elected to the Duke University Board of Trustees in 2011 and currently serves on the Executive Committee, Audit, Risk and Compliance Committee, and he chairs the Business and Finance Committee. Mr. Hawkins is also a member of the Board of the Duke University Health System.
Mr. Hawkins also serves as a Member of the Advisory Boards at Arboretum Ventures, Radius Ventures, LLC, HealthQuest Ventures, Accuitive Medical Ventures, A*STAR SERC Cluster Advisory Board in Singapore, and the Biomedical Sciences International Advisory Council, Singapore (“BMS IAC”).
